242 related articles for article (PubMed ID: 30359892)
1. Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications.
Burke SL; Hu T; Spadola CE; Li T; Naseh M; Burgess A; Cadet T
Sleep Med; 2018 Dec; 52():168-176. PubMed ID: 30359892
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Sleep Disturbance May Reduce the Risk of Future Probable Alzheimer's Disease.
Burke SL; Hu T; Spadola CE; Burgess A; Li T; Cadet T
J Aging Health; 2019 Feb; 31(2):322-342. PubMed ID: 30160576
[TBL] [Abstract][Full Text] [Related]
3. Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia.
Burke SL; Maramaldi P; Cadet T; Kukull W
Int Psychogeriatr; 2016 Sep; 28(9):1409-24. PubMed ID: 27020605
[TBL] [Abstract][Full Text] [Related]
4. The Relationship Between Sleep Disturbance and Apolipoprotein E ε4 in Adults With Mild Cognitive Impairment and Alzheimer's Disease Dementia: An Integrative Review.
Wei W; Wang K; Shi J; Li Z
Biol Res Nurs; 2022 Jul; 24(3):327-337. PubMed ID: 35439097
[TBL] [Abstract][Full Text] [Related]
5. Prescription Medications for the Treatment of Insomnia and Risk of Suicide Attempt: a Comparative Safety Study.
Lavigne JE; Hur K; Kane C; Au A; Bishop TM; Pigeon WR
J Gen Intern Med; 2019 Aug; 34(8):1554-1563. PubMed ID: 31161572
[TBL] [Abstract][Full Text] [Related]
6. Zolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis.
Assimon MM; Flythe JE
Clin J Am Soc Nephrol; 2020 Dec; 16(1):88-97. PubMed ID: 33355192
[TBL] [Abstract][Full Text] [Related]
7. APOE e4 genotype and cigarette smoking in adults with normal cognition and mild cognitive impairment: a retrospective baseline analysis of a national dataset.
Kalapatapu RK; Delucchi KL
Am J Drug Alcohol Abuse; 2013 Jul; 39(4):219-26. PubMed ID: 23808899
[TBL] [Abstract][Full Text] [Related]
8. The Effect of the APOE ε2ε4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non-Latino Whites.
Ren D; Lopez OL; Lingler JH; Conley Y
J Am Geriatr Soc; 2020 May; 68(5):1044-1049. PubMed ID: 32017008
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
Basta M; Zaganas I; Simos P; Koutentaki E; Dimovasili C; Mathioudakis L; Bourbouli M; Panagiotakis S; Kapetanaki S; Vgontzas A
J Alzheimers Dis; 2021; 79(2):763-771. PubMed ID: 33361595
[TBL] [Abstract][Full Text] [Related]
10. Disturbed sleep patterns in elders with mild cognitive impairment: the role of memory decline and ApoE ε4 genotype.
Hita-Yañez E; Atienza M; Gil-Neciga E; Cantero JL
Curr Alzheimer Res; 2012 Mar; 9(3):290-7. PubMed ID: 22211488
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
13. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study.
Sakurai R; Montero-Odasso M
J Gerontol A Biol Sci Med Sci; 2017 Nov; 72(12):1676-1682. PubMed ID: 28482102
[TBL] [Abstract][Full Text] [Related]
15. Five-Year Change in Body Mass Index Predicts Conversion to Mild Cognitive Impairment or Dementia Only in APOE ɛ4 Allele Carriers.
Kadey KR; Woodard JL; Moll AC; Nielson KA; Smith JC; Durgerian S; Rao SM
J Alzheimers Dis; 2021; 81(1):189-199. PubMed ID: 33749649
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.
Burke SL; Maramaldi P; Cadet T; Kukull W
Arch Gerontol Geriatr; 2016; 65():231-8. PubMed ID: 27111252
[TBL] [Abstract][Full Text] [Related]
17. Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
Stanitsa E; Economou A; Beratis I; Kontaxopoulou D; Fragkiadaki S; Papastefanopoulou V; Pavlou D; Papantoniou P; Kroupis C; Papatriantafyllou J; Stefanis L; Yannis G; Papageorgiou SG
J Alzheimers Dis; 2021; 84(3):1005-1014. PubMed ID: 34602476
[TBL] [Abstract][Full Text] [Related]
18. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
[TBL] [Abstract][Full Text] [Related]
19. Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.
Bangen KJ; Clark AL; Werhane M; Edmonds EC; Nation DA; Evangelista N; Libon DJ; Bondi MW; Delano-Wood L;
J Alzheimers Dis; 2016 Mar; 52(3):849-61. PubMed ID: 27031472
[TBL] [Abstract][Full Text] [Related]
20. APOE ε4, Alzheimer's disease neuropathology and sleep disturbance, in individuals with and without dementia.
Blackman J; Love S; Sinclair L; Cain R; Coulthard E
Alzheimers Res Ther; 2022 Mar; 14(1):47. PubMed ID: 35354468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
